- Home
- Publications
- Publication Search
- Publication Details
Title
Future directions in inflammatory bowel disease management
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 8, Issue 8, Pages 726-734
Publisher
Oxford University Press (OUP)
Online
2014-04-16
DOI
10.1016/j.crohns.2014.02.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Letter: dry blood spots for anti-TNF treatment monitoring in IBD
- (2013) N. Vande Casteele et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Biosimilar monoclonal antibodies: a science-based regulatory challenge
- (2013) Paul J Declerck EXPERT OPINION ON BIOLOGICAL THERAPY
- Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients
- (2013) Scott Plevy et al. INFLAMMATORY BOWEL DISEASES
- Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
- (2013) Koji Atarashi et al. NATURE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations
- (2013) Paul Chamberlain Bioanalysis
- Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease
- (2012) J. L. Anderson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The role of biosimilars in the treatment of rheumatic diseases
- (2012) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- Food and the gut microbiota in inflammatory bowel diseases
- (2012) Lindsey G. Albenberg et al. CURRENT OPINION IN GASTROENTEROLOGY
- How to Guide Therapeutic Decisions in a Patient-Tailored Approach to Treatment of IBD?
- (2012) Paul Rutgeerts DIGESTIVE DISEASES
- Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease
- (2012) Francesc Casellas et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease
- (2012) Geert D'Haens et al. GASTROENTEROLOGY
- Patient-Specific Approach to Combination Versus Monotherapy with the Use of Antitumor Necrosis Factor α Agents for Inflammatory Bowel Disease
- (2012) Shane M. Devlin et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Fecal Microbiota Transplantation
- (2012) Thomas Julius Borody et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- TheNOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis
- (2012) Andrea D Tyler et al. GUT
- Mucosal Healing in Crohnʼs Disease
- (2012) Peter De Cruz et al. INFLAMMATORY BOWEL DISEASES
- The future of inflammatory bowel disease management: Combining progress in trial design with advances in targeted therapy
- (2012) Simon Travis et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease
- (2012) S. Schreiber et al. Journal of Crohns & Colitis
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- Setting the stage for biosimilar monoclonal antibodies
- (2012) Christian K Schneider et al. NATURE BIOTECHNOLOGY
- Interchangeability, immunogenicity and biosimilars
- (2012) Hans C Ebbers et al. NATURE BIOTECHNOLOGY
- The advent of biosimilar therapies in rheumatology—“O Brave New World”
- (2012) Morton A. Scheinberg et al. Nature Reviews Rheumatology
- A Glimpse of the Next 100 Years in Medicine
- (2012) Isaac S. Kohane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis
- (2012) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
- (2011) L. S. Kiss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
- (2011) Matthias Jürgens et al. Clinical Gastroenterology and Hepatology
- Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
- (2011) Pal Miheller et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
- (2011) Cosimo Prantera et al. GASTROENTEROLOGY
- Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior
- (2011) Gary R. Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease
- (2011) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- Long-term Durability of Infliximab Treatment in Crohnʼs Disease and Efficacy of Dose “Escalation” in Patients Losing Response
- (2011) María Chaparro et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Fecal microbiota transplantation and emerging applications
- (2011) Thomas J. Borody et al. Nature Reviews Gastroenterology & Hepatology
- Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
- (2011) G. D. Wu et al. SCIENCE
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
- (2010) Matthias Jürgens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
- (2010) Stefan Schreiber et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
- (2010) Dario Sorrentino et al. Clinical Gastroenterology and Hepatology
- Genetic predictors of medically refractory ulcerative colitis
- (2010) Talin Haritunians et al. INFLAMMATORY BOWEL DISEASES
- Predictive value of epithelial gene expression profiles for response to infliximab in Crohnʼs disease‡
- (2010) Ingrid Arijs et al. INFLAMMATORY BOWEL DISEASES
- Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases
- (2010) Daniel N. Frank et al. INFLAMMATORY BOWEL DISEASES
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis
- (2010) Boyko Kabakchiev et al. PLoS One
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
- (2010) K. Atarashi et al. SCIENCE
- What is the optimal therapy for Crohn’s disease: step-up or top-down?
- (2010) Ming Valerie Lin et al. Expert Review of Gastroenterology & Hepatology
- Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients
- (2009) Liesbet Henckaerts et al. Clinical Gastroenterology and Hepatology
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Importance of mucosal healing in ulcerative colitis
- (2009) Gary R. Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
- (2009) Taina Sipponen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Metagenomic Approaches for Defining the Pathogenesis of Inflammatory Bowel Diseases
- (2008) Daniel A. Peterson et al. Cell Host & Microbe
- Microbial Influences in Inflammatory Bowel Diseases
- (2008) R. Balfour Sartor GASTROENTEROLOGY
- Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
- (2008) Miguel Regueiro et al. GASTROENTEROLOGY
- Analysis of bacterial bowel communities of IBD patients: What has it revealed?
- (2008) Harry Sokol et al. INFLAMMATORY BOWEL DISEASES
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now